« back

Joint translational funding from Action Medical Research and LifeArc

  Wednesday, 14 Jun 2023 | Funding Deadline

Action Medical Research and LifeArc want to improve the lives of children suffering from rare disease and are working together to co-fund translational, rare disease research projects. Co-funding aims to accelerate promising, cutting-edge medical research that could have a significant impact on the treatment of infants, children and young people (CYP) with any of the >7000 heterogeneous conditions collectively called ‘rare disease’.

The joint fund will be used to support biomedical research projects from across the UK that have moved beyond a basic understanding of rare disease mechanism into the development of an intervention (therapeutic, diagnostic, or device).

Deadline for proposals: 14 June 2023
Find out more here